% Expired Patents = 100.0

CIPO Patents = 1

EPO Patents = 3

Forward Citations = 5

Loading Chart...

13 inventors (with patents filed for the assignee):

Nicholas M Dean (6 out of 54 patents)

C Frank Bennett (5 out of 203 patents)

Niall O'Donnell (5 out of 9 patents)

4. J Gordon Foulkes (5 out of 6 patents)

5. Susan M Frier (3 out of 3 patents)

6. Susan M Freier (1 out of 263 patents)

7. Thomas A Mustoe (1 out of 6 patents)

8. Lincoln Krochmal (1 out of 1 patent)

9. Leroy Young (1 out of 2 patents)

10. Mark Jewell (1 out of 1 patent)

11. Mark Sisco (1 out of 1 patent)

12. Zol Kryger (1 out of 1 patent)

13. Gregory E Hardee (1 out of 9 patents)

14. Niall O'donnell (1 patent)

15. Frank C Bennet (0 patent)

6 patents: Sort by Forward Citations

1. 9688987 - Antisense oligonucleotides directed against connective tissue growth factor and uses thereof (2017-06-27),

2. 9173894 - Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (CTGF) (2015-11-03),

3. 9096851 - Antisense oligonucleotides directed against connective tissue growth factor and uses thereof (2015-08-04),

4. 8946172 - Method for reducing scarring during wound healing using antisense compounds directed to CTGF (2015-02-03),

5. 8772260 - Methods for inhibiting expression of connective tissue growth factor (2014-07-08),

6. 8252762 - Antisense oligonucleotides directed against connective tissue growth factor and uses thereof (2012-08-28),

Company Overview

Excaliard Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing novel treatments for fibrotic diseases. Their lead product candidate is a proprietary anti-sense oligonucleotide designed to prevent the formation of excessive scar tissue. The company's mission is to improve the lives of patients suffering from debilitating fibrotic conditions through innovative therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#1,027 in New York, NY

#2,695 in New York

#44,981 in US

New York, NY, United States of America

Excaliard Pharmaceuticals, Inc.

Forward Citations = 5

13 inventors:

Nicholas M Dean (6 out of 54 patents)

C Frank Bennett (5 out of 203 patents)

Niall O'Donnell (5 out of 9 patents)

4. J Gordon Foulkes (5 out of 6 patents)

5. Susan M Frier (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Excaliard Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/excaliard-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]